XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net income $ 98,668 $ 31,388
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 12,406 12,148
Amortization of deferred debt issuance costs 4,256 4,558
Amortization 41,445 41,724
Stock-based compensation 19,336 18,334
Deferred income taxes 5,626 (891)
Non-cash adjustments to fair value of contingent consideration liability (42,267) 6,949
Increase (decrease) in cash flows from changes in assets and liabilities:    
Accounts receivable 10,781 (38,015)
Inventories (24,436) 5,286
Accounts payable 15,345 8,133
Accrued compensation and benefits (8,063) 5,461
Other assets (10,293) (21,978)
Other liabilities 826 (4,144)
Net cash provided by operating activities 123,630 68,953
Cash flows from investing activities:    
Purchases of property, plant and equipment (9,044) (14,177)
Other 0 (1,000)
Net cash used in investing activities (9,044) (15,177)
Cash flows from financing activities:    
Payments on revolving line of credit (567,000) (560,000)
Proceeds from revolving line of credit 601,000 512,000
Payments to redeem convertible notes (70,000) 0
Payments related to contingent consideration (48,084) 0
Dividends paid on common stock (18,474) (18,353)
Other, net 2,628 14,687
Net cash used in financing activities (99,930) (51,666)
Effect of exchange rate changes on cash and cash equivalents (485) (550)
Net increase in cash and cash equivalents 14,171 1,560
Cash and cash equivalents at beginning of period 24,296 28,942
Cash and cash equivalents at end of period 38,467 30,502
Non-cash financing activities:    
Dividends payable $ 6,178 $ 6,149